Sharma B, Chalikwar R, Bhalerao S, Gondane A, Pawar D, Sharma A
Cureus. 2024; 16(9):e69146.
PMID: 39398799
PMC: 11467699.
DOI: 10.7759/cureus.69146.
Garnier A, Drablier G, Briet M, Augusto J
Drug Saf. 2023; 46(8):715-724.
PMID: 37310614
DOI: 10.1007/s40264-023-01316-1.
Sighinolfi M, Eissa A, Bevilacqua L, Zoeir A, Ciarlariello S, Morini E
Paediatr Drugs. 2019; 21(5):323-344.
PMID: 31541411
DOI: 10.1007/s40272-019-00355-5.
Azarkar G, Birjand M, Ehsanbakhsh A, Bijari B, Abedini M, Ziaee M
Drug Healthc Patient Saf. 2018; 10:103-108.
PMID: 30588126
PMC: 6296198.
DOI: 10.2147/DHPS.S183892.
Daudon M, Frochot V, Bazin D, Jungers P
Drugs. 2017; 78(2):163-201.
PMID: 29264783
DOI: 10.1007/s40265-017-0853-7.
Characterizing ceftriaxone-induced urolithiasis and its associated acute kidney injury: an animal study and Chinese clinical systematic review.
Zhang Y, Ning B, Zhu H, Cong X, Zhou L, Wang Q
Int Urol Nephrol. 2016; 48(7):1061-9.
PMID: 27126355
DOI: 10.1007/s11255-016-1273-4.
Increasing urinary calcium excretion after ceftriaxone and cephalothin therapy in adults: possible association with urolithiasis.
Otunctemur A, Ozbek E, Polat E, Cekmen M, Dursun M, Cakir S
Urolithiasis. 2013; 42(2):105-8.
PMID: 24310104
DOI: 10.1007/s00240-013-0627-y.
Urinary sludge caused by ceftriaxone in a young boy.
Kimata T, Kaneko K, Takahashi M, Yamanouchi S, Tsuji S, Kino M
Pediatr Rep. 2012; 4(1):e14.
PMID: 22690306
PMC: 3357613.
DOI: 10.4081/pr.2012.e14.
Ceftriaxone associated urolithiasis in a child with hypercalciuria.
Lozanovski V, Gucev Z, Avramoski V, Kirovski I, Makreski P, Tasic V
Hippokratia. 2011; 15(2):181-3.
PMID: 22110305
PMC: 3209686.
Increased urinary calcium excretion caused by ceftriaxone: possible association with urolithiasis.
Kimata T, Kaneko K, Takahashi M, Hirabayashi M, Shimo T, Kino M
Pediatr Nephrol. 2011; 27(4):605-9.
PMID: 22038204
DOI: 10.1007/s00467-011-2038-z.
Nephrolithiasis caused by ceftriaxone in a 3-year-old child with ureteropelvic junction obstruction.
Stojanovic V, Djuric Vijatov G
Case Rep Med. 2009; 2009:365962.
PMID: 19718430
PMC: 2729447.
DOI: 10.1155/2009/365962.
Ceftriaxone associated nephrolithiasis: a prospective study in 284 children.
Mohkam M, Karimi A, Gharib A, Daneshmand H, Khatami A, Ghojevand N
Pediatr Nephrol. 2007; 22(5):690-4.
PMID: 17226043
DOI: 10.1007/s00467-006-0401-2.
Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children.
Avci Z, Koktener A, Uras N, Catal F, Karadag A, Tekin O
Arch Dis Child. 2004; 89(11):1069-72.
PMID: 15499067
PMC: 1719698.
DOI: 10.1136/adc.2003.044156.
Drug-induced renal calculi: epidemiology, prevention and management.
Daudon M, Jungers P
Drugs. 2004; 64(3):245-75.
PMID: 14871169
DOI: 10.2165/00003495-200464030-00003.
